Enhanced Mitochondrial Function and Delivery from Adipose-Derived Stem Cell Spheres via the EZH2-H3K27me3-PPARγ Pathway for Advanced Therapy

doi:10.21203/rs.3.rs-5151447/v1

Download PDF

Research Article

Enhanced Mitochondrial Function and Delivery from Adipose-Derived Stem Cell Spheres via the EZH2-H3K27me3-PPARγ Pathway for Advanced Therapy

https://doi.org/10.21203/rs.3.rs-5151447/v1

This work is licensed under a CC BY 4.0 License

You are reading this latest preprint version

Background

Microenvironmental alterations induce significant genetic and epigenetic changes in stem cells. Mitochondria, essential for regenerative capabilities, provide the necessary energy for stem cell function. However, the specific roles of histone modifications and mitochondrial dynamics in human adipose-derived stem cells (ASCs) during morphological transformations remain poorly understood. In this study, we aim to elucidate the mechanisms by which ASC sphere formation enhances mitochondrial function, delivery, and rescue efficiency.

Methods

ASCs were cultured on chitosan nano-deposited surfaces to form 3D spheres. Mitochondrial activity and ATP production were assessed using MitoTracker staining, Seahorse XF analysis, and ATP luminescence assays. Single-cell RNA sequencing, followed by Ingenuity Pathway Analysis (IPA), was conducted to uncover key regulatory pathways, which were validated through molecular techniques. Pathway involvement was confirmed using epigenetic inhibitors or PPARγ-modulating drugs. Mitochondrial structural integrity and delivery efficiency were evaluated after isolation.

Results

Chitosan-induced ASC spheres exhibited unique compact mitochondrial morphology, characterized by condensed cristae, enhanced mitochondrial activity, and increased ATP production through oxidative phosphorylation. High expressions of mitochondrial complex I genes and elevated levels of mitochondrial complex proteins were observed without an increase in reactive oxygen species (ROS). Epigenetic modification of H3K27me3 and PPARγ involvement were discovered and confirmed by inhibiting H3K27me3 with the specific EZH2 inhibitor GSK126 and by adding the PPARγ agonist Rosiglitazone (RSG). Isolated mitochondria from ASC spheres showed improved structural stability and delivery efficiency, suppressed the of inflammatory cytokines in LPS- and TNFα-induced inflamed cells, and rescued cells from damage, thereby enhancing function and promoting recovery.

Conclusion

Enhancing mitochondrial ATP production via the EZH2-H3K27me3-PPARγ pathway offers an alternative strategy to conventional cell-based therapies. High-functional mitochondria and delivery efficiency show significant potential for regenerative medicine applications.

Enhanced mitochondrial function

adipose-derived stem cells

3D spheroid culture

chitosan nano-deposition

EZH2-H3K27me3-PPARγ pathway

mitochondrial therapy

Regenerative medicine aims to restore damaged tissues using stem cell-based interventions, with particular emphasis on adipose-derived stem cells (ASCs) due to their abundance and multilineage differentiation capacity that similar to bone marrow mesenchymal stem cells (MSCs)(1–3). Several methods have been developed to promote sphere formation in adult stem cells, including hanging drop, gel embedding, magnetic levitation, and spinner culture (4, 5). Multicellular systems in 3D, such as organoids, assembloids, and/or organ-on-chip models, have been vigorously developed to mimic organ functions for studying cancer, genetic disorders, infectious diseases, and neurological diseases (4, 5). The formation of cell spheres involves self-assembly without external substrates or scaffolds. Self-assembly occurs during embryogenesis, morphogenesis, and organogenesis, and can be modulated by chemical, cellular, and microenvironmental factors (6). Spheroid culture of ASCs or MSCs on chitosan-coated surface promotes the expression of stemness markers such as Oct4 and Nanog transcription factors and secretory factors important for cell viability, migration, and tissue regenerations (7, 8). Chitosan, a polysaccharide derived from N-deacetylated chitin found in the exoskeletons of crustaceans and insects, possesses highly biocompatible and biodegradable properties and is widely used in biomaterials for gene delivery, cell culture, and tissue engineering. The hyaluronan-grafted chitosan surface also induced the chondrogenic markers when co-culturing ASCs with chondrocytes and assembling them into co-spheroids (9). Additionally, chitosan-coated microenvironments can be used to sequential assembly of core-shell structures for dermal papilla spheres with an outer layer of ASCs to promote hair follicle induction (10).

Mitochondria, crucial organelles ranging from 0.5-1.0 µm in size, are essential for cellular energy production by oxidizing nutrients like carbohydrates, fats, and amino acids (11). They harbor their genetic material and play pivotal roles in metabolic pathways like the tricarboxylic acid (TCA) cycle and fatty acid β-oxidation. Mitochondrial dynamics and morphology are regulated by fission, fusion, shape transition, and cytoskeletal arrangements (12, 13). Fission involves inner membrane division and outer membrane scission, while fusion merges outer membranes followed by inner membrane joining. Shape transition controls the shift between rounded and elongated mitochondrial forms independently of fission/fusion. Mitochondrial positioning is facilitated by transport along the cytoskeleton, crucial for stable energy supply and axon maintenance in neurons. In mature cells, mitochondrial morphology undergoes dynamic changes in response to energy demands, appearing fragmented during low demand and elongated with well-developed inner membrane structures during high demand (14, 15). Mitochondria continuously remodel through fission to divide into smaller units for mitophagy and fusion to combine into larger structures for energy production (16, 17).

Mitochondrial therapy shows promise in modulating cell metabolism, immune responses, tissue homeostasis, mitochondrial integrity, wound healing, and anti-inflammatory processes across various conditions such as acute lung injury (18), cardiac ischemic injury (19), acute myocardial infraction (20), spinal cord injury (21), stroke (22). Dysfunction of mitochondria is notably linked to diseases or injury due to their pivotal role in energy metabolism, redox homeostasis, and signaling pathways (23). Elevated reactive oxygen species (ROS) levels in diabetic wounds result from mitochondrial respiratory leakage and impaired cellular antioxidant defenses. Impaired mitochondria under oxidative stress release mitochondrial DNA (mtDNA), mtROS, and excessive calcium, activating the nucleotide-binding and oligomerization domain (NOD)-like receptor thermal protein domain associated protein 3 (NLRP3) inflammasomes. Mitochondrial dysfunction, leading to reduced ATP production and cell death, can be ameliorated by restoring mitochondrial content, function, and homeostasis, thus enhancing the functionality of impaired cells. Recent studies indicate the potential for mitochondria and mitochondrial DNA transfer between cells through mechanisms like tunneling nanotubes, mitochondria-derived vesicles, mitochondria-captured extracellular vesicles, and cell-free mitochondria (24). Mitochondria can be internalized into cells without the need for transfection reagents, utilizing processes such as macropinocytosis and caveolae-dependent endocytosis (25).

Mitochondria are also recognized as key regulators of stem cell fate and function, primarily through mitochondrial metabolism and oxidative phosphorylation (OXPHOS) in the respiratory chain (26). Increased mitochondrial biogenesis and aerobic metabolism are distinctive features of MSC differentiation, whereas mitochondrial dysfunction inhibits this process (27). Mitochondrial networks in stem cells appear fragmented, while differentiated cells exhibit elongated tubular structures. Mitochondria enable stem cells to adapt effectively to variations in their microenvironmental conditions and play a pivotal role in metabolic regulation, acting as switches controlling stem cell differentiation and pluripotency (28). In 2D culture, the ratio of mitochondrial area to cytoplasm increases during differentiation, suggesting the critical role of fusion/fission dynamics and mitochondrial morphology in maintaining stem cell properties (29). The arrangement of mitochondria changes before and after MSC differentiation, with undifferentiated MSCs exhibiting perinuclear mitochondrial organization compared to the even distribution in differentiated MSCs (30). MSC-mediated mitochondrial transfer has been investigated in various studies to exploit their therapeutic potential for repairing damaged tissues/cells (31). Mitochondria isolated from human MSCs were nasally administered to mice, quickly reaching the meninges and being internalized by macrophages, distributing to diverse brain regions and restoring brain structure and function in cisplatin-induced cognitive deficits (32). Local mitochondrial injection has improved regenerative muscle functions by enhancing mitochondrial dynamics and OXPHOS in muscle cells (33). Additionally, mitochondrial transplantation through intracerebral or intraarterial injection has rescued neuronal mitochondrial dysfunction in preclinical studies of acute central nervous system injuries and neurodegenerative disorders (34). Currently, most of mitochondria therapy involves isolated mitochondria from regular 2D MSCs or ASCs culture condition. Although stem cell behavior and function are enhanced in 3D assembly, little is known about how microenvironmental cues influence stem cell metabolic activities and their mitochondrial morphologies and functions.

Understanding the relationship between sphere formation and mitochondrial function for stem cells is an important research direction to explore the regulatory mechanisms for regenerative medicine. During ASC sphere formation, our recent single-cell RNA sequencing (scRNA-seq) study identified different cell subpopulations and epigenetic changes particularly histone modifications like histone 3 at lysine 4 (H3K4), lysine 9 (H3K9), and lysine 27 (H3K27) trimethylation are involved on ASC reprogramming and differentiation (35). Epigenetic regulation plays a vital role in stem cell fate and functions (36), however, the detailed mechanism underlying histone trimethylation-mediated subpopulations and their mitochondrial function in ASC spheres in responses to the biomaterial microenvironments remains incompletely understood. Furthermore, while stem cell-derived compounds such as exosomes or mitochondria may play crucial roles in mediating therapeutic effects, the mechanisms governing mitochondrial internalization to rescue the damaged cells are not fully elucidated. This study aims to explore the interplay of epigenetic modifications during the assembly of ASC sphere formation and their influences on mitochondrial morphologies and functions. The contribution of chitosan nano-deposited surface and the plasticity of ASCs in the interplay of epigenetic regulation, mitochondria features, functions, isolation, and delivery are critical for enhancing the therapeutic components in stem cells and further advancing regenerative medicine.

A detailed list of chemicals and materials used in this study is provided in Supplementary Material 1, Table S1.

Cell culture conditions

Human ASCs, MSCs harvested from normal human adipose tissue (C12977, hMSC-AT), were purchased from PromoCell GmBH and cultured in a mixture of 25% mesenchymal stem cell growth medium (C28009, PromoCell) and 75% Dulbecco’s modified Eagle’s medium high glucose (DMEM-high; 12400-061, Gibco), supplemented with 10% fetal bovine serum (FBS; Hyclone) and 1% penicillin/streptomycin (P/S) (Gibco). Hs68 cells (BCRC No. 60038), a human foreskin fibroblast cell line, were obtained from the Bioresource Collection and Research Center (BCRC) of Food Industry Research and Development Institute (FIRDI, Hsinchu, Taiwan), and the rat schwannoma cell line RT4 (RT4-D6P2T, ATCC CRL-2768) was acquired from ATCC. Both Hs68 and RT4 cells were cultured in DMEM-high media supplemented with 10% FBS and 1% P/S. All cells were maintained in a humidified incubator with 5% CO2 at 37 °C.

3D sphere induction

For chitosan-induced sphere formation, cells were seeded onto the chitosan-coated surface at a density of 1 × 10⁶ cells in 10 ml growth media on a 9 cm plate to induce spheroid formation for 72 hours as following the established protocols (35, 37). For sphere formation in ultra-low attachment (ULA) microplates (7007, Corning), 3000 cells were seeded per well in 200 μl growth media to assembly the 3D spheres for 72 hours.

Pathway inhibitors and treatments

The epigenetic inhibition compounds were added to the growth media at the same time as sphere induction: 70 μM SNDX-5613 (Revumenib, a KMT2A inhibitor) targeting KMT2A (MLL1) to reduce H3K4me3, 25 nM SUVi (Chateocin, a SUV39H1 inhibitor) to block H3K9me3, 10 μM GSK126 (an EZH2 inhibitor) for inhibiting H3K27me3, and 500 nM LMK235 as a HDAC5 inhibitor. The Food and Drug Administration (FDA)-approved peroxisome proliferator-activated receptor gamma (PPARγ) agonist, Rosiglitazone (RSG), was used to investigate the gain-of-function in PPARγ signaling. The PPARγ antagonist, GW9662, was applied to verify the loss-of-function in the PPARγ pathway. The RSG or GW9662 were added to the growth media during sphere formation at the concentration of 2, 5, 10, and 20 μM.

Mitochondrial staining, observation, and artificial intelligence-based Classification

Prior to sphere formation on chitosan-coated surface, ASCs were incubated with MitoTracker™ Deep Red FM dye at a concentration of 30nM for 45 min at 37°C. After labeling the mitochondria, cells were washed twice with PBS to remove excess dye. Following 3 days of sphere formation, the spheres were rinsed once with PBS and fixed with 4% paraformaldehyde (PFA, EM grade) in PBS at 4°C overnight. To observe the mitochondria with cytoskeleton arrangement, rhodamine-phalloidin dye (R415, Thermo Fisher Scientific) was added and incubated overnight at 4°C. Subsequently, the spheres were rinsed three times with PBS, permeabilized by 0.5% Triton X-100 for 2 hours, and then mounted using ProLong® Diamond Antifade Mountant with DAPI in the dark. Confocal microscopy was utilized to examine mitochondrial morphology using the Olympus FluoView™ FV3000 confocal microscope (Olympus, Japan).

For defining and quantifying MitoTracker-labeled mitochondrial shapes, the "Maximum Extent Inner" feature in the cellSens software was employed. This feature represents the maximum length of a line connecting two boundary points within the object. Subsequently, classification was performed using an artificial intelligence (AI) machine-learning-based mitochondrial neural network within Olympus cellSens Dimension software (Olympus, Japan), categorizing them into three classes based on their inner lengths: Fragmented (0.7-1.2 μm), Tubular (1.21-4.5 μm), and Compact (or Clustered) (4.51 μm and beyond). The quantification of MitoTracker fluorescent intensities in different categorized mitochondria was normalized to cell numbers by nuclei staining using DAPI or Hoechst 33342.

Transmission electron microscopy analysis of the mitochondrial ultrastructure

Collected 3D spheres and adherent ASCs were rinsed with pre-cooled PBS and then immersed in a fixative solution containing 2.5% glutaraldehyde and 3 mM CaCl₃in 0.1M cacodylate buffer for 1 hour at 4°C. The adherent 2D-cultured ASCs were then scraped into a tube. After washing with 0.1M cacodylate buffer containing 3mM CaCl3, cells underwent post-fixation by immersion in 0.1M cacodylate buffer containing 1% osmium tetroxide and 1.5% potassium ferricyanide at 4°C for 40 min. Following the post-fixation step, the samples were washed with distilled water and then gradually dehydrated by immersion in a series of ethanol solutions with increasing concentrations: 70%, 90%, and 95%, with each stage lasting 15 min. Subsequently, the samples were immersed in 100% ethanol three times, with each immersion lasting 30 min. The dehydrated samples were then infiltrated in stages with spur resin–ethanol solutions containing 50%, then 75%, and finally 100% resin, with each stage lasting 1 hour. After overnight incubation in 100% spur resin suppression, the specimens were embedded in fresh resin and polymerized at 70°C for 24 hours. The embedded samples were sectioned into 70 nm ultrathin slices using an ultramicrotome (Ultracut S, Leica Reichart) equipped with a diamond knife, and the sections were collected on nickel grids. These grids were subsequently post-stained with uranyl acetate and lead citrate. TEM analysis was performed using a JEM-1400 transmission electron microscope (JEOL, Ltd., Japan) operating at 120 keV, coupled with a 4k x 4k CCD Camera System 895 (UltraScan 4000, Gatan Inc., USA).

Single-cell RNA sequencing assay

The scRNA-seq data from this study build upon an important aspect of our previous research. The procedures for scRNA-seq libraries preparation, sequencing, and analysis for 2D-cultured ASCs and 3D ASC spheres were detailed in a prior publication (35). Monocle 2 software (38) was used for trajectory analysis to explore cell fate and cluster associations for investigating the cell differentiation trajectories between ASCs and chitosan-induced ASC spheres. The gene expression pattern analysis and directional predictions were conducted using Ingenuity Pathway Analysis software (IPA®, QIAGEN Inc, CA, USA).

Western blotting analysis

The 2D-cultured ASCs or 3D ASC spheres were lysed using a cell lysis buffer (9083; Cell Signaling Tech) supplemented with a protease inhibitor cocktail (7012; Cell Signaling Tech) and PMSF (8553, Cell Signaling Tech). The protein concentration was measured using a Bio-Rad protein assay dye (Bio-Rad Laboratories Inc., USA). Thirty micrograms of total protein were loaded in Western blotting analysis in according to previous study (37, 39). The target proteins were immunoblotted with specific antibodies (detailed in Table S2), and signal visualization was achieved using Trident femto Western HRP Substrate and a UVP EC3 imaging system (UVP Inc., Upland, CA, USA). The quantification of signal intensity was performed using ImageJ software (Image J, NIH).

ATP production detection assay

An ATP luminescence detection assay kit (A22066, Molecular Probes, Inc.; Invitrogen, Ltd., UK) was used to measure the ATP production of 2D-cultured ASCs and 3D ASC spheres, following the experiment procedure outlined in the manufacturer's instructions. In brief, ten micrograms of total protein in a 10 μl cell lysate were mixed with 100 μl of assay buffer containing D-Luciferin, DTT, and firefly luciferase. The luciferase intensity was then measured at 560 nm. The ATP concentration was normalized by total protein.

Real-time assessment of mitochondrial function using the Seahorse system

Mitochondrial oxygen consumption rates (OCR) and extracellular acidification rates (ECAR) were assessed using the Seahorse XFe24 Analyzer (Agilent, Santa Clara, CA, USA). The procedures were carried out according to the manufacturer's instruction manual. In brief, a XFe24 cell culture microplate was coated with fibronectin (FN, 20 μg/ml) and incubated at 37°C for 30 min. For 2D-cultured ASCs, 5000 cells were seeded onto the FN-coated plates one day before the experiment. For 3D spheroid formation, spheres were transferred and settled in microplates for an hour before the Seahorse assay.

Mitochondrial respiration was analyzed under basal conditions and in response to sequential injections of Oligomycin (1.5 μM), fluoro-carbonyl cyanide phenylhydrazone (FCCP, 1 μM), and Rotenone/Antimycin (0.5 μM each) using the Seahorse XF Cell MitoStress Test Kit. Real-time measurements for each drug were recorded over 5 cycles of 3 min in the Seahorse XF Cell Mito Stress Test program in Wave Controller 2.4 software (Agilent). The OCR was normalized to total protein content per well. The ATP production rates were determined using the Seahorse XF Real-Time ATP Rate Assay Kit following the recommended protocol. Data sets were analyzed using the Wave software and Excel software.

RNA extraction, reverse transcriptase PCR and real-time PCR analysis

Total RNA was extracted from ASCs or spheres using TRIzol reagent (Invitrogen Corp., Carlsbad, CA, USA) and the Direct-zol RNA Miniprep kit (Zymo Research, Inc., CA, USA), following the manufacturer’s protocol. The concentration of total RNA was determined by measuring absorbance at 260 and 280 nm using a nucleic acid spectrometer (Nanodrop ND1000, Thermo Fisher Scientific). Two micrograms of total RNA were reverse-transcribed into cDNA using the SuperScript II Reverse Transcriptase Kit (Invitrogen). The real-time PCR (qPCR) analysis was conducted using the SYBR Green Master Mix (Thermo Scientific) and ABI StepOne PlusTM (Applied Biosystems). The qPCR conditions were as follows: 50°C for 2 min, 95 °C for 2 min, and 45 cycles of 95 °C for 3 seconds (s) and 60 °C for 20 s, followed by routine melting and cooling steps. The primer pairs used for qPCR in current study were listed in Table S3. GAPDH was employed as the reference gene for mRNA levels, and each sample was examined in triplicate. The fold change for target gene expression was calculated using the ∆∆Ct method.

ROS assay

The cellular ROS assay kit (Ab113851, Abcam) was used to detect the occurrence of oxidative stress during 3D sphere formation. In 2D-cutlured ASCs, adherent ASCs were seeded on an 8-well chamber slide and rinsed once with PBS before being stained with 2', 7'-dichlorofluorescin diacetate (DCFDA) for 1 hour. To detect the ROS in spheres, the 3D-assembled spheres were collected in a conical tube by centrifugation and rinsed once in PBS. The spheres were stained by resuspending them in the DCFDA solution and incubating at 37°C for 3 hours. After removing the DCFDA solution, the spheres were rinsed with PBS and resuspended in complete media without phenol red, supplemented with 10% FBS. Nuclei were stained with Hoechst 33342 for 30 min before microscopy examination.

Nuclear/Cytosol fractionation

To separate the nuclear extract from the cytoplasmic fraction of cells, the Nuclear Extraction Kit (No. 10009277, Cayman Chemical Inc., MI, USA) was used. Briefly, adherent 2D-cultured ASCs were washed with PBS containing protease inhibitors and then scraped into the hypotonic buffer. For 3D spheroids, chitosan-induced ASC spheres were transferred to a centrifuge tube and collected by centrifugation at 800 rpm for 5min, after which the medium was discarded. Spheres were then washed with PBS containing protease inhibitors and centrifuged again before being resuspended in the hypotonic buffer. After a 15-min incubation, 200 μl of 10% NP-40 per ml of hypotonic buffer was added, and the mixture was centrifuged at 14,000 g for 30 seconds at 4°C. The supernatant containing the cytosolic fraction was transferred to a new tube. The pellet was washed twice with ice-cold PBS and resuspended in the nuclear extraction buffer. To isolate the nuclear proteins, the suspension was vortexed vigorously for 15 seconds, incubated on ice for 15 min, followed by a 30-second vortex, and another 15-min incubation on ice. Finally, the supernatant containing the nuclear fraction was collected by centrifugation at 14,000 g for 10 min at 4°C. Both the nuclear and cytoplasmic protein fractions were stored at -80°C for further analyses.

PPARγ transcription factor assay

The specific transcription factor DNA binding activity of PPARγ was detected using a PPARγ transcription factor assay kit (Ab133101, Abcam), following the manufacturer's protocol. Briefly, ten micrograms of total protein in a 10 μl cell lysate were mixed with 90 μl Transcription Factor Binding Assay Buffer (TFB) per well of 96-well plate and incubated overnight ar 4°C without agitation. After five PBS washes, PPARγ primary antibody was added and incubated at room temperature for 1 hour. Subsequently, after five PBS washes, the second antibody (goat anti-rabbit HRP conjugate) was added and incubated for 1 hour. To each well, 100 µl of developing solution was added and incubated for 15 min. The colorimetric absorbance was read at 450 nm within five min of adding the stop solution.

Cell inflammation models and cell-free mitochondrial transfer experiments

A. Isolation of enhanced mitochondria from spheres: Mitochondria in 2D-cultured ASCs or chitosan-induced 3D spheres were extracted using Mitochondria Isolation Kit for cultured cells (Abcam, ab110170). Cells and spheres were collected by centrifugation at 800 rpm for 5 min, rinsed once with PBS, and subjected to a freeze-thaw process to disrupt the cell membrane. The samples from different groups were then suspended in Reagent A for 10 min and homogenized with 30 strokes using a Dounce homogenizer. The resultant mixture was centrifuged at 4000 rpm for 10 min. The supernatant containing Reagent A was collected. Next, Reagent B was added to resuspend the cell pellet, followed by a 10-min incubation, cell homogenization, and another centrifugation at 4000 rpm for 10 min. The combined supernatants (Reagent A and B) were centrifuged at 12000 rpm for 15 min. The pellet was washed once with PBS, centrifuged again. After removing the PBS, the mitochondria were resuspended in growth media, and then administered to inflamed cells. Approximately 50 μg of mitochondria, quantified using the Bio-Rad protein assay, can be extracted from spheres formed by 1 × 10⁶ ASC cells in a 9 cm chitosan-coated dish after 72 hours of culture. To visualized the extracted mitochondria, the MitoTracker™ Deep Red FM dye (red fluorescent color) were applied to ASCs or ASC spheres for staining and tracing the mitochondria prior isolation. The extracted mitochondria (exMito) were freshly applied for in vitro cell rescue experiments.

B. Inflamed cell models and treatments: For investigating the anti-inflammation and cell rescue outcome, RT4 cells (2.5 × 10⁵ cells) were seeded in 6 cm culture dishes overnight and then subjected to 20 μg/ml lipopolysaccharide (LPS) or 10 ng/ml Tumor Necrosis Factor-α (TNFα) for 3 hours. The extracted mitochondria (50 μg) from various stem cell groups were added to the inflamed RT4 cells growing in a 10 cm plate and incubated for additional 48 hours. The RT4 cells were harvested for Western blotting to measure the inflammatory protein expressions, and qPCR for cytokine mRNA expressions.

To observe the delivery of exMito and the intracellular mitochondrial dynamics between exMito and endogenous mitochondria, the RT4 cells were first labeled with MitoTracker™ Green FM dye (green fluorescent color) for 45 min at 37°C before inflammatory induction by LPS or TNFα. After applying the exMito from different treatment groups for 48 hours, the inflamed RT4 cells were observed using living cell confocal microscopy (Olympus FluoView™ FV3000, Olympus Corp., Japan). Fluorescent-labeled mitochondria were visualized along with the nuclei stain using Hoechst 33342 (NucBlue Live Ready Probes Reagent, Thermo Fisher Scientific) to investigate the mitochondrial morphologies and interactions between exMito (red) and endogenous mitochondria (green) within the cells.

Statistical analysis

Statistical analysis was conducted utilizing GraphPad Prism 6 software (GraphPad, La Jolla, CA, USA). A significant threshold of p-value <0.05 was applied to determine statistical significance in this study. Specific statistical methods corresponding to each figure were detailed in the respective Figure Legends.

Chitosan nanodeposited surface induced 3D ASC spheres formation and mitochondria morphological changes

To assess mitochondrial morphology during sphere formation when seeding human ASCs on a chitosan-coated surface, we conducted mitochondrial staining with MitoTracker™ Deep Red FM dye and examined the 3D images using confocal microscopy at 24, 48, and 72 hours (Supplementary Material 2, Fig. S1 and Movies 1–6). When double-stained with F-actin, the interactions between stress fibers and mitochondrial distribution were observed in ASCs and ASC spheres (Fig. 1A). In 2D-cultured spread out ASCs, mitochondria were elongated, branched, and formed tubular networks in the cytosol to compose the mitochondria network with cytoskeleton. During 3D sphere formation on the chitosan surface, F-actin was distributed on cell surface and the mitochondria exhibited a higher MitoTracker intensity with round and compact morphologies near the cell nucleus (Fig. 1A).

To further quantify changes in mitochondrial morphology, the MitoTracker-stained mitochondria were categorized into fragmented, tubular, and compact types using Artificial Intelligence (AI)-based mitochondrial neural network software (Fig. 1B). The compact mitochondria (green color in AI analysis) showed higher expression in ASC spheres and was quantified by a significant increase in the normalized image area of compact-type mitochondria compared to tubular-type mitochondria (yellow color in AI analysis) in 2D-cultured ASCs (Fig. 1B). The Transmission Electron Microscopy (TEM) was used to further explore mitochondrial ultrastructure in ASCs in response to chitosan-induced sphere formation. Mitochondria in ASCs displayed a wide, elongated oval shape with fewer cristae and a more spaced-out arrangement (Fig. 1C). Conversely, mitochondria within 3D ASC spheres showed shorter and compacted features with compact cristae and reduced spacing.

To confirm the contribution of chitosan nano-deposition (CS) to mitochondrial induction during 3D sphere formation, the formation of ASC sphere was also assembled by seeding ASCs in an ultra-low attachment (ULA) 96-well plate. The ULA surface also promoted ASC sphere formation, but MitoTracker staining showed much less mitochondria intensity than in CS-induced ASC spheres (Fig. 1D). These results suggest the chitosan-coated surface not only benefit ASC sphere assembly but also induces mitochondria morphological changes during 3D sphere formation.

ASC sphere formation induced specific mitochondria subpopulation

To further understand the genetic changes at the single-cell level during ASC sphere formation, scRNA-seq analysis was conducted to compare the 2D ASC culture and 3D ASC spheres (35). The scRNA-seq revealed a novel cell population within ASC spheres, Cluster 4, which is characterized by its top ten genes that all associated with mitochondrial respiratory enzymes (Fig. 2A; Table S4). The cell trajectory analysis illustrated that Cluster 4 in 3D spheres originated from Cluster 0 in ASCs (Fig. 2B). Among these upregulated genes, the MT-ATP8 gene, which encodes a subunit of ATP synthase in mtDNA and crucial for OXPHOS on ATP production, is highly expressed in Cluster 4 cells (Fig. 2C, subpopulation in red circle area). The MT-ND2, MT-ND4L, MT-ND5, and MT-ND6 were also highly expressed in Cluster 4 cells (Fig. 2C). These genes encode subunits of NADH dehydrogenase for mitochondria complex I to play a primary role in electrons entering the respiratory chain and serving as a rate-limiting step in overall respiration and energy production. Additionally, other mitochondrial associated genes, such as MT-ND1, MT-ND3, MT-ND4, MT-ATP6, MT-CO1, MT-CO3, and MT-CYB, also increased after spheroid formation (Fig. S2; Table S4). The increases in complex I, II, and IV proteins were confirmed by western blotting analysis after ASC sphere formation (Fig. 2D).

Enhancing mitochondrial ATP production after sphere formation and the essential roles of chitosan and ASCs

To further explore changes in mitochondrial morphology and genes, the ATP production functionality was measured using a bioluminescent ATP detection assay and revealed significant increases in ATP production after ASCs sphere formation at 24, 48, and 72 hours (Fig. 3A). The Seahorse Cell Mito Stress Analysis results showed a significant increase of mitochondrial oxygen consumption rates (OCR) in spheres after fluoro-carbonyl cyanide phenylhydrazone (FCCP) injection, indicating the activation of OXPHOS in sphere mitochondria compared to 2D-cultured ASCs (Fig. 3B). The Seahorse Real-Time ATP Rate Assay demonstrated significant increases in both mitochondrial and glycolytic ATP in ASC spheres (Fig. 3C), but the increase was primarily in mitochondrial ATP after forming spheroid on chitosan-coated microenvironment. To confirm the role of chitosan in sphere-induced ATP production, we examined mitochondrial activation in a 3D sphere formation microenvironment between CS surface and ULA plates. Similar to the aforementioned mitochondria staining results, although ASCs could also form spheres in ULA plate (Fig. S3A), the ATP production did not increase compare to 2D-cultured ASCs (Fig. 3D). Additionally, we investigated whether chitosan-induced mitochondrial activation and ATP production are exclusive to ASCs. The human foreskin fibroblast (Hs68 cells) were cultured in CS or ULA microenvironments to form 3D spheres (Fig. S3B). Although Hs68 cells also formed spheres on CS surface, the ATP productions decreased in both CS and ULA Hs68 spheres (Fig. 3E). These results suggested that 3D assembly of sphere alone is not sufficient to activate mitochondria for energy production. The presence of chitosan surface and the use of ASCs are necessary factors to enhance mitochondrial ATP production in ASC spheres. Additionally, chitosan-induced sphere formation in ASCs leads to enhanced mitochondrial function, as evidenced by increased expression of genes associated with mitochondrial respiratory enzymes, suggesting a potential mechanism for improving OXPHOS energy production.

Regulatory network and H3K27me3-EZH2 pathway for mitochondrial activations in ASC spheres

To identify the potential downstream factors influenced by histone modification enzymes in mitochondrial respiration, we utilized IPA software to predict candidates by considering epigenetic regulators and the top 30 highly expressed genes in Cluster 4. The activated and inhibited effects of the signaling pathway for mitochondrial functions associate with mitochondria complex I genes and nuclear epigenetic regulation were illustrated using the Molecule Activity Predictor (MAP) overlay tools in the Ingenuity Pathway Analysis (IPA) software (Fig. 4A). Since histone trimethylation of H3K4me3, H3K9me3, and H3K27me3, and HDAC5 were previously identified in ASC spheres (35), the involvement of potential epigenetic regulators for mitochondrial functions during ASC sphere formation was examined by employing specific inhibitors of SNDX-5613, SUVi, GSK126, and LMK235 to reduce H3K4me3, H3K9me3, H3K27me3, and HDAC5, respectively. The MitoTracker Deep Red FM-labeled ASCs were seeded on chitosan-coated surface and subjected to different inhibitors for 3 days. Confocal microscopy images showed decreases in MitoTracker fluorescent intensities for the mitochondria within spheres treated with various epigenetic and HDAC5 inhibitors, particularly in GSK126-treated spheres (Fig. 4B). Spheres treated with GSK126 to inhibit H3K27me3 and EZH2 enzyme displayed predominantly punctate mitochondrial patterns and weaker fluorescence intensity. The AI quantitative analysis of mitochondria morphology also indicated that GSK126-treated spheres exhibited less compacted and filamentous mitochondria (Fig. 4C). When using the bioluminescent ATP detection assay to investigate the influence of epigenetic inhibitors on ATP production, only the GSK126 inhibitor showed a significant reduction in ATP production (Fig. 4D). Other epigenetic inhibitors, SNDX-5613, SUVi, and LMK235, did not significantly inhibit sphere-induced ATP production. The Seahorse assay further demonstrated that GSK126 treatment abolished the sphere-induced ATP production in the OCR to attenuate sphere maximal respiration and spare respiratory capacity (Fig. 4E). These results agreed with the ATP synthesis assays and real-time ATP production rate measurements that GSK126 significantly reduced total ATP synthesis, especially impacting mitochondrial ATP levels (Fig. 4F). Thus, the important roles of EZH2 and H3K27me3 in ATP production were discovered for boosting mitochondria ATP during ASC sphere formation.

PPARγ as EZH2 key downstream pathway to boost mitochondria functions during ASC sphere formation

According to IPA predictions, the EZH2 enzyme directly targets to PPARγ (also known as PPARG) and CEBPA for regulating a wide range of mitochondrial proteins. The PPARG, PPARG coactivator 1 alpha (PPARGC1A), PPARG coactivator 1 beta (PPARGC1B), sterol regulatory element-binding protein 1 (SREBF1), and transcription factor for Immunoglobulin Heavy-Chain Enhancer 3 (TEF3) were suggested to be the potential signals influencing mitochondrial genes. Other genes, like pyruvate kinase M1/2 (PKM), signal transducer and activator of transcription 3 (STAT3), and mitochondrial transcription factor A (TFAM), were also identified for mitochondrial functions. The increases of mRNA levels in PPARγ, PPARGC1A, PPARGC1B, SREBF1, TFAM, TEF3, and STAT3 genes, as conformed by qPCR analysis, indicate the activation of PPARγ and its associated pathways during sphere formation (Fig. 5A). Additionally, these ASC sphere-induced genes were significantly inhibited by GSK126 treatment. The glycolytic enzyme PKM is responsible for converting phosphoenolpyruvate into pyruvate (40). The decrease of PKM mRNA levels in spheres also suggests that ATP production during sphere formation may predominantly occur through mitochondrial ATP generation. Furthermore, the application of GSK126 in ASC spheres abolished mitochondrial ATP and increased the PKM gene, which may switch to glycolytic ATP (Fig. 5A). The involvement of PPARγ pathways was verified by Western Blotting during sphere formation with or without the EZH2 inhibitor GSK126 (Fig. 5B). The inhibition of the EZH2 enzyme during sphere formation not only blocked H3K27me3 but also inhibited the sphere-induced expressions of PPARγ and STAT3. Other epigenetic and HDAC5 inhibitors including SNDX, SUVi, and LMK235, were also investigated for their effects on blocking H3K4me3, H3K9me3, and HDAC5, as well as on the aforementioned mRNA (Fig. S4) and protein (Fig. S5) expressions. Some mitochondrial target genes were inhibited by the SUVi inhibitor, such as PPARγ, PPARGC1B, TFE3, SREBF1, and STAT3, but these inhibitions were not as broad as that observed with GSK126.

Mitochondria generate O2•− for electron transport mainly in complex I and complex III. However, a small fraction of oxygen escapes from the mitochondria during the process of ATP production may contribute to ROS formation. To further investigate whether the increases of mitochondrial complex I in ASC spheres will induce ROS levels, we used DCFDA microscopic staining to observe the cellular ROS between 2D-cutlured ASC and chitosan-coated 3D ASC spheres. Similar to other studies showing low ROS levels in ASCs (41), the ROS expression was almost undetectable in 2D spread-out ASCs and could be triggered by the common inflammation inducer, lipopolysaccharide (LPS) (Fig. 5C, ASC groups). Although complex I genes and proteins increased in ASC spheres, the ROS levels remained low (Fig. 5C, sphere control). Inhibition of the EZH2 enzyme by GSK126 during ASC sphere formation increased ROS production (Fig. 5C, sphere with GSK). These findings suggest that mitochondrial complex I in ASC spheres is independent of ROS production when seeding ASCs on a chitosan-coated surface. Moreover, blocking the EZH2 enzyme during sphere formation increased ROS, further highlighting the important role of H3K27me3 in high functional mitochondrial production in ASC spheres.

To ascertain the role of PPARγ in the mitochondrial function of ASC spheres, the PPARγ agonist RSG that commonly used for type II diabetes mellitus treatment was applied to confirm the gain-of-function in PPARγ regulatory mechanism during sphere formation. The PPARγ antagonist GW9662 was also used to test the lost-of-function in PPARγ pathway. Treatment with both RSG and GW9662 during sphere formation resulted in dose-dependent effects on sphere size (Fig. 5D, phase images for sphere morphologies in Fig. S6A). Sphere size was significantly increased in response to the 10 and 20 µM RSG treatment, while it significantly decreased with 10 and 20 µM GW9662 treatment. The expressions of PPARγ protein also exhibited a dose-dependent pattern in response to treatment with either the PPARγ agonist or antagonist (Fig. S6B). The nuclear and cytosol fraction further demonstrated that PPARγ expressions were majorly located in the nucleus and increased when treating with RSG (Fig. 5E). The PPARγ promoter assay also confirmed the additional increase of transcriptional activity when applying RSG during ASC sphere formation (Fig. 5F). The PPARγ agonist further increased the mitochondria complex protein expressions during ASC sphere formation, especially in complex I and III (Fig. S6C). The impact of PPARγ on ASC sphere mitochondrial function was investigated by Seahorse measurements and demonstrated that 10 µM of RSG significantly enhanced OXPHOS in ASC spheres, while 10 µM of GW9662 inhibited sphere-induced OCR and mitochondrial energy production (Fig. 5G). The ROS levels were assessed with the application of PPARγ agonist or antagonist during ASC sphere formation and showed low intracellular ROS when treating with PPARγ agonist (Sph + RSG), whereas the ROS was slightly elevated in ASC sphere with PPARγ antagonist treatment (Sph + GW9662) (Fig. S6D). Taken together, these results confirmed the regulatory mechanism of the EZH2-H3K27me3-PPARγ pathway in ASC sphere formation to enhance mitochondrial function and energy production.

Sphere-enhanced mitochondria rescue inflamed cells and integrate with endogenous mitochondria

In cell-based therapy, our previous research demonstrated that ASC spheres could promote the repair and regeneration of transected sciatic nerves in rats, particularly by inhibiting inflammation and promoting the remyelination in Schwann cells (37, 42). Given the significant changes in mitochondrial morphology and function during sphere formation, we investigated the therapeutic potential of mitochondria derived from 2D-cultured ASCs and chitosan-induced 3D ASC spheres. To evaluate the anti-inflammatory and cell rescue effects, the mitochondria were freshly isolated from ASCs or ASC spheres and immediately administered to inflamed cells. The TEM images demonstrated that sphere-enhanced mitochondria were easily obtained through the extraction procedures and maintained intact ultrastructure with compacted cristae (Fig. 6A). These sphere-enhanced mitochondria also formed a lipid cluster after isolation.

Cellular inflammation and damage were induced by in vitro applying 20 µg/ml LPS or 10 ng/ml TNFα to rat schwannoma RT4 cells. After 3 hours of LPS or TNFα stimulation, freshly extracted mitochondria (exMito) from 2D-cultured ASCs (ASC), chitosan-induced 3D ASC spheres (Sph), and 10 µM RSG-treated ASC spheres (Sph + RSG) were administered to the inflamed cells for 48 hours. Apoptosis markers, including cleaved PARP, BAX, cleaved Caspase-3, and cleaved Caspase-9, increased in inflamed RT4 cells under LPS (Fig. 6B) or TNFα (Fig. S7A) induction. The administration of mitochondria extracted from ASC spheres (Sph) or those treated with a PPARγ agonist (Sph + RSG) rescued cells and reduced the expression of apoptosis-related protein (Fig. 6B and Fig. S7A). Pro-inflammatory genes induced by LPS (Fig. 6C) or TNFα (Fig. S7B) at the mRNA level, including TNFα, IL-1β, IL-6, and COX-2, were inhibited following the application of the exMito from ASC spheres with or without RSG (significantly different from LPS-induced RT4 group, marked as ‘a’). Additionally, the administration of exMito from ASC sphere treated with a PPARγ agonist (Sph + RSG) further increased the anti-inflammatory cytokine IL-10 compared to exMito treatment from 2D-cultured ASC (significant difference labeled as ‘b’) and 3D ASC spheres (significant difference labeled as ‘c’) (Fig. 6C). Furthermore, the number and morphology of RT4 cells, which were altered by LPS or TNFα stimulation, were rescued by exMito treatments (Fig. S7C).

To trace and verify the uptake of exMito by inflamed cells, MitoTracker Deep Red FM dye was used to label ASC mitochondria prior to spheroid formation and mitochondrial isolation (exMito labeled in red). MitoTracker Green FM dye was used to label the endogenous mitochondria in RT4 cells to observe the mitochondrial dynamics in response to inflammation and different exMito administrations. After 48 hours of LPS-induced inflammation, endogenous mitochondria became fragmented and damaged, as indicated by their shortened morphology (Fig. 6D, RT4-Mito labeled in green). The weakened RT4-Mito fluorescence intensity in LPS-injured cells was rescued by administering any type of exMito from 2D-cultured ASC (ASC) or ASC spheres with or without RSG (Sphere or Sphere + RSG) (Fig. 6E, quantification of green fluorescent intensity compared to LPS group). Endogenous mitochondria in RT4 cells exhibited elongated filamentous morphologies and higher fluorescence when receiving exMito from ASC spheres or spheres with additional RSG (Fig. 6D-E, green fluorescent in the Sph and Sph + RSG groups). Both exMito isolated from the Sph and Sphere + RSG groups showed increased exMito intensities compared to exMito from ASC, indicating higher delivery of sphere-enhanced mitochondria after 3D spheroid formation (Fig. 6D-E, red fluorescent). We also observed that both administered exMito from ASC spheres (both Sph and Sph + RSG groups) merged or were in close proximity to endogenous mitochondria (RT4-Mito), suggesting the possibility of integration or fusion between endogenous and extracted mitochondria (see enlarged images of areas I and II). Quantification of fluorescent intensities in RT4-Mito and exMito demonstrated that the PPARγ agonist (RSG) further improved mitochondrial delivery and transfer into damaged cells to inhibit inflammation (Fig. 6E, with significantly differences labeled ‘b’ or ‘c‘ to indicate comparisons with LPS + exMito from ASC or Sph groups, respectively). The inflammation and rescue by exMito delivery were double-confirmed in a TNFα-induced model (Fig. S7D-E). Labeling and tracing exMito provide direct evidences to demonstrate how ASCs compact the functional enhanced mitochondria during sphere formation and show better delivery and integration of these enhanced mitochondria to rescue inflammation and repair damaged cells.

Taken together, these results reveal that chitosan-coated surfaces can promote ASCs to form 3D spheres, facilitating the compacted morphological features and enhanced ATP production. These sphere-enhanced mitochondria are regulated via the EZH2-H3K9me3-PPARγ pathway to boost mitochondrial functions. Additionally, sphere-enhanced mitochondria exhibit better structural stability and deliver efficiency to direct transfer into damaged cells for repair and rescue. A schematic outline of the novel discoveries in current study is summarized in Fig. 7.

Mitochondria function is integral to cellular homeostasis and plays a crucial role in various physiological processes, including tissue repair and regeneration. Several studies have highlighted the therapeutic potential of mitochondria transfer in diverse injury and disease models such as acute lung injury (18), cardiac ischemic injury (19), acute myocardial infraction (20), spinal cord injury (21), and stroke (22). Mitochondria can be incorporated into cells through macropinocytosis and caveolae-dependent endocytosis, eliminating the need for transfection reagents or interventions (25). Nasal administration of human MSC-derived mitochondria has shown promise in reversing chemotherapy-induced cognitive deficits (32). Mitochondria isolated from human MSCs and administered nasally can rapidly reached the meninges, internalized by macrophages, and distributed to multiple brain regions for successfully restoring both brain structure and function in cisplatin-induced cognitive deficits mice. Local injection of mitochondria can also restore the fission-impaired or aged satellite cells by improving mitochondrial dynamics (activate fission or prevent fusion), OXPHOS, or mitophagy to promote the regenerative muscle functions (33). Humans generally exhibit good tolerance to cell-free mitochondria, as evidenced by the presence of cell-free mitochondria in normal blood components (43) and high levels of extracellular mitochondria and mitochondria-associated extracellular vesicles in blood (44). Although the field of mitochondrial transfer experiments is rapidly advancing, further research and exploration are still needed to understand the detailed mechanisms and potential therapeutic applications of mitochondrial therapy.

Mitochondria not only reflect cellular status in diseases but also play important roles in the functionality of stem or progenitor cells during regeneration. ASCs harvested from type II diabetes patients showed enlarged nuclei, degenerated mitochondrial cristae, and decreased mitochondrial enzyme activity compared to ASCs from healthy donors (45). The aging or genetic impairment of resident quiescent muscle stem cell (satellite cells) leads to loss of mitochondrial fission, dysregulation of the mitochondrial electron transport chain, inefficient OXPHOS metabolism, increased oxidative stress, and subsequent failure of muscle regeneration (33). Using scRNA-seq, the mitochondrial membrane potential for glycolysis and metabolic properties were compared between quiescent and cycling-primed hematopoietic stem cell which demonstrated an increased lysosomal sequestration of mitochondria to enhance the competitive repopulation ability and therapeutically relevant in primed cells (46). Mitochondria are also central regulators of cell fate determination in neural stem cells for neurodevelopment, adult neurogenesis, and cognitive function (47). The morphology and distribution of mitochondria serve as indicators of mitochondrial cristae development for respiratory chain complex assembly during MSC osteogenic differentiation (48). During osteogenic differentiation, the changes in MSC mitochondria processes can be inhibited by ROS (49, 50). Conversely, ROS levels rise as MSCs transform into adipocytes during adipogenesis (51, 52). In addition, adult stem cells gradually lose their adaptive capacity due to aging and impaired function of energy-producing mitochondria. Enhancing mitochondrial function in stem cells is, therefore, an important area of research. How to boost the mitochondria in stem cell is also an important topic. The current study discovered a convenient strategy to facilitate both mitochondria energy production (Fig. 3) and morphology (Fig. 1) by assembling stem cells into 3D spheres on chitosan-coated surfaces. These features can benefit the high-yield extraction, stable structure during delivery, and the rescue of damaged endogenous mitochondria to repair or restore cell functions (Fig. 6).

In stem cell, the H3K27me3 is critical for maintaining stemness, while H3K27me2 triggers cellular differentiation (53). Methylation of H3K27 and H3K9 is usually linked to gene silencing, whereas methylation of H3K4 is associated with actively transcribed genes (36). Our previous study revealed the subpopulations and gene expression profiles in ASC spheres to discover their cell cycle and reprogramming signaling network regulated by epigenetic factors (35). The interplay between the H3K4me3, H3K9me3, HDAC5 epigenetic modifiers, and their target regulators (KMT2A, SUV39H1, and HDAC5) during chitosan-induced sphere formation was associated with arresting ASC proliferation and promoting of reprogramming potential. The current study further illustrates the pivot role of EZH2 in mitochondrial functions during ASC sphere formation and mitochondria ATP production (Fig. 4). Mechanistically, EZH2, a member of the polycomb repressive complex 2 (PRC2), has multiple splicing modes and performs various physiological functions. Female mice with a short form of EZH2 (Ezh2Short) displayed abnormal mitochondrial function and accumulated H3K27me3 in Ezh2Short oocytes, significantly reducing fertility and obstructing oogenesis (54). Modulations of EZH2 phosphorylation have shown divergent effects on mitochondrial function, influencing cellular growth, differentiation, and ATP levels (55).

The second major player in sphere-enhanced mitochondria regulatory mechanism is PPARγ, a member of the nuclear receptor superfamily of ligand-inducible transcription factors. PPARγ binds to PPAR-responsive regulatory elements for regulating adipogenesis, lipid metabolism, inflammation, and maintaining metabolic homeostasis (56–58). PPARGC1A and PPARGC1B are two coactivators of PPARγ that contribute to energy homeostasis and metabolism. PPARγ plays anti-inflammatory roles in obesity, metabolic syndrome, insulin resistance/insufficiency, type 2 diabetes mellitus (58), and inflammation (59–61). It also been reported to regulate mitochondrial structure and function (62). The RSG has been reported to reduce diabetes angiopathy by inhibiting mitochondrial dysfunction via regulation of heat shock protein 22 expression (63). The addition of a PPARγ agonist or antagonist during ASC sphere formation revealed that the PPARγ signal can altered sphere size (Fig. 5D) and further improve ATP production in ASC spheres by adding RSG during spheroid formation (Fig. 5G). The interactions between the epigenetic regulator and the PPARγ signal were predicted by IPA in current study (Fig. 4A) and confirmed by molecular measurements to demonstrate that PPARγ and EZH2 can influence each other (Fig. 5A, 5C, and 5E). Blockage of the relative signaling network with the EZH2 inhibitor GSK126 confirmed the epigenetic regulation of H3K27me3 and its downstream targets of PPARγ and mitochondrial genes (Fig. 5A and 5C). Although RSG treatment increased PPARγ signaling during sphere formation and further boosted the therapeutic potential of mitochondria, RSG is commonly found in adipogenesis medium for MSC differentiation into adipocytes. The long-term effects of RSG treatment during ASC spheroid formation and its influence on differentiation markers require further investigation in future studies. Thus, the current study revealed that the EZH2-H3K27me3-PPARγ regulatory pathway plays an important role in sphere-enhanced mitochondria functions during ASC spheroid formation.

Changes in the microenvironment directly influence cellular metabolic processes, subsequently affecting mitochondrial function. Sphere formations alter mitochondrial morphology, especially in cells deprived of oxygen and nutrients at the sphere center (64). Moreover, a detailed understanding of cell-cell and cell-microenvironment interactions in spheres, particularly regarding epigenetic regulation for mitochondria function, has not been investigated previously. This study utilized scRNA-seq to provide insights into the epigenetic regulatory mechanisms during sphere formation and discovered a special subpopulation (Cluster 4) that promotes the mitochondrial function and ATP production (Fig. 2). Although the underlying mechanism and potential mechanobiological factors that control the change of mitochondrial morphology during 3D stem cell assembly remain unknown, our unpublished data observed some association with cytoskeleton rearrangements during sphere formation. For the extracted mitochondria and potential mitochondrial therapy, future studies can focus on tracing these donor mitochondria (exMito) and elucidating the potential mechanism in the in vivo repair and regenerative microenvironments in living animals.

Through scRNA-seq and rigorous cell fate trajectory analyses, we identified distinct cell subpopulations enriched in mitochondrial functions within spheres formed by seeding ASCs on chitosan-coated surface. Cluster 4 cells are regulated via the EZH2-H3K27me3-PPARγ pathway to upregulate mitochondria complex I genes for producing ATP in spheres. Administration of extracted mitochondria from ASC spheres successfully rescued the LPS-induced cell damage and inflammation. External high-ATP mitochondria were taken up by injured cells and integrated with endogenous mitochondria to restore mitochondrial morphology and functions. The supplementation of the PPARγ agonist Rosiglitazone during sphere formation further increased the ATP production and boosted the rescue capacity of mitochondria therapy. These innovative discoveries and strategies may provide potential therapeutic applications in regenerative medicine and clinical interventions.

ASC Adipose-derived stem cells

CS Chitosan-coated surface

ECAR Extracellular acidification rates

exMito Extracted mitochondria

EZH2 Enhancer of zeste 2 polycomb repressive complex 2 subunit

FBS Fetal bovine serum

FN Fibronectin

H3K4me3 Histone 3 lysine 4 trimethylation

H3K9me3 Histone 3 lysine 9 trimethylation

H3K27me3 Histone 3 lysine 27 trimethylation

HDAC5 Histone deacetylase 5

IPA Ingenuity Pathway Analysis software

LPS Lipopolysaccharide

MSC Mesenchymal stem cells

mtDNA Mitochondrial DNA

FCCP Carbonylcyanide-p-trifluoromethoxyphenylhydrazone

KMT2A Histone-lysine N-methyltransferase 2A

OCR Oxygen consumption rate

OXPHOS Oxidative phosphorylation

PKM Pyruvate kinase M1/2

PPARγ/PPRG Peroxisome proliferator-activated receptor gamma

PPARGC1A PPARG coactivator 1 alpha

PPARGC1B PPARG coactivator 1 beta

ROS Reactive oxygen species

RSG Rosiglitazone

scRNA-seq Single-cell RNA sequencing)

Sph Spheres

SREBF1 Sterol regulatory element-binding protein 1

STAT3 Signal transducer and activator of transcription 3

TEF3 Transcription factor for Immunoglobulin Heavy-Chain Enhancer 3

TEM Transmission Electron Microscopy

TFAM Mitochondrial transcription factor A

TNFα Tumor Necrosis Factor-α

ULA Ultra-low attachment plate

Acknowledgments

We express gratitude for optical microscopy technical services provided by the Bioimaging Core Facility of the National Core Facility Program for Biotechnology, National Science and Technology Council, Taiwan. Additionally, we thank the National Center for High-performance Computing (NCHC) at the National Applied Research Laboratories (NARLabs) in Taiwan for generously providing computational and storage resources. The authors declare that no AI-generated editorial work or autonomous content creation was used in this manuscript.

Author Contributions:

MMC and CCW conceived the project and designed the experiments. MMC performed experimentsand acquired the data. MMC and CCW analyzed data and interpreted the results. MMC and CCW contributed to the Methodology. DTC, SCL, JSL, SPL and CCW helped in the Methodology. MMC, DTC, TDV, HTV and CCW prepared the original draft; MMC, DTC, SCL, JSL, TDV, HTV, TSR, SPL and CCW reviewed and revised the manuscript. MMC and CCW visualized the study. SCL, JSL, TSR, SPL provided technical expertise and intellectual contributions. All authors read and approved the final manuscript. CCW contributed to supervision and project administration. MMC and CCW contributed to funding acquisition.

Funding

This study was supported by grants from the National Science and Technology Council of Taiwan: NSTC113-2320-B-006-046 (CCW), NSTC111-2320-B-006-069-MY2 (MMC), NSTC113-2320-B-006-042-MY3 (MMC), and the National Health Research Institutes of Taiwan, grant NHRI-EX111-10925EI (CCW).

Data Availability

All data are available in the main text or the supplementary materials. Additional experimental details and data used or analyzed during the current study can be obtained from the corresponding author upon reasonable request. The scRNA-seq data reported in this article has been deposited in NCBI’s Gene Expression Omnibus (GEO) under accession number GSE250358. The data is currently private and is scheduled to be released on December 16, 2027, or upon the publication of this manuscript.

Ethics approval and consent to participate

This article does not include any studies involving human participants conducted by any of the authors. Human ASCs (C12977, hMSC-AT) used in this research were purchased from PromoCell GmbH. Detailed information regarding compliance and prior ethical approval can be found on the company's official website: PromoCell Compliance. The Hs68 cell line (BCRC No. 60038) was obtained from BCRC of FIRDI, Hsinchu, Taiwan. The Material Transfer Agreement (MTA) and product certificates are included in Supplementary Material 5.

Consent for publication

Not applicable.

Competing Interests

The authors declare no conflict of interest.

Aly RM. Current state of stem cell-based therapies: an overview. Stem Cells Int. 2020;7:8.
Pittenger MF, Discher DE, Peault BM, Phinney DG, Hare JM, Caplan AI. Mesenchymal stem cell perspective: cell biology to clinical progress. NPJ Regen Med. 2019;4:22.
Zuk PA. The adipose-derived stem cell: looking back and looking ahead. Mol Biol Cell. 2010;21(11):1783-7.
Goldrick C, Guri I, Herrera-Oropeza G, O'Brien-Gore C, Roy E, Wojtynska M, et al. 3D multicellular systems in disease modelling: From organoids to organ-on-chip. Front Cell Dev Biol. 2023;11:1083175.
Vogt N. Assembloids. Nat Methods. 2021;18(1):27.
Ryu NE, Lee SH, Park H. Spheroid Culture System Methods and Applications for Mesenchymal Stem Cells. Cells. 2019;8(12).
Cheng NC, Chen SY, Li JR, Young TH. Short-term spheroid formation enhances the regenerative capacity of adipose-derived stem cells by promoting stemness, angiogenesis, and chemotaxis. Stem Cells Transl Med. 2013;2(8):584-94.
Ho SS, Murphy KC, Binder BY, Vissers CB, Leach JK. Increased Survival and Function of Mesenchymal Stem Cell Spheroids Entrapped in Instructive Alginate Hydrogels. Stem Cells Transl Med. 2016;5(6):773-81.
Yeh HY, Hsieh FY, Hsu SH. Self-patterning of adipose-derived mesenchymal stem cells and chondrocytes cocultured on hyaluronan-grafted chitosan surface. Biointerphases. 2016;11(1):011011.
Huang CF, Chang YJ, Hsueh YY, Huang CW, Wang DH, Huang TC, et al. Assembling Composite Dermal Papilla Spheres with Adipose-derived Stem Cells to Enhance Hair Follicle Induction. Sci Rep. 2016;6:26436.
Borcherding N, Jia W, Giwa R, Field RL, Moley JR, Kopecky BJ, et al. Dietary lipids inhibit mitochondria transfer to macrophages to divert adipocyte-derived mitochondria into the blood. Cell Metab. 2022;34(10):1499-513 e8.
Tilokani L, Nagashima S, Paupe V, Prudent J. Mitochondrial dynamics: overview of molecular mechanisms. Essays Biochem. 2018;62(3):341-60.
Fenton AR, Jongens TA, Holzbaur ELF. Mitochondrial dynamics: Shaping and remodeling an organelle network. Curr Opin Cell Biol. 2021;68:28-36.
Norat P, Soldozy S, Sokolowski JD, Gorick CM, Kumar JS, Chae Y, et al. Mitochondrial dysfunction in neurological disorders: Exploring mitochondrial transplantation. npj Regen Med. 2020;5(1):22.
Zhang S, Zhao J, Quan Z, Li H, Qing H. Mitochondria and Other Organelles in Neural Development and Their Potential as Therapeutic Targets in Neurodegenerative Diseases. Front Neurosci. 2022;16:853911.
Westermann B. Mitochondrial fusion and fission in cell life and death. Nat Rev Mol Cell Biol. 2010;11(12):872-84.
Youle RJ, van der Bliek AM. Mitochondrial fission, fusion, and stress. Science. 2012;337(6098):1062-5.
Islam MN, Das SR, Emin MT, Wei M, Sun L, Westphalen K, et al. Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury. Nat Med. 2012;18(5):759-65.
Han H, Hu J, Yan Q, Zhu J, Zhu Z, Chen Y, et al. Bone marrow-derived mesenchymal stem cells rescue injured H9c2 cells via transferring intact mitochondria through tunneling nanotubes in an in vitro simulated ischemia/reperfusion model. Mol Med Rep. 2016;13(2):1517-24.
Kaza AK, Wamala I, Friehs I, Kuebler JD, Rathod RH, Berra I, et al. Myocardial rescue with autologous mitochondrial transplantation in a porcine model of ischemia/reperfusion. J Thorac Cardiovasc Surg. 2017;153(4):934-43.
Lin MW, Fang SY, Hsu JC, Huang CY, Lee PH, Huang CC, et al. Mitochondrial Transplantation Attenuates Neural Damage and Improves Locomotor Function After Traumatic Spinal Cord Injury in Rats. Front Neurosci. 2022;16:800883.
Zhang Z, Ma Z, Yan C, Pu K, Wu M, Bai J, et al. Muscle-derived autologous mitochondrial transplantation: A novel strategy for treating cerebral ischemic injury. Behav Brain Res. 2019;356:322-31.
Jiang G, Jiang T, Chen J, Yao H, Mao R, Yang X, et al. Mitochondrial dysfunction and oxidative stress in diabetic wound. J Biochem Mol Toxicol. 2023;37(7):e23407.
Borcherding N, Brestoff JR. The power and potential of mitochondria transfer. Nature. 2023;623(7986):283-91.
Main EN, Cruz TM, Bowlin GL. Mitochondria as a therapeutic: a potential new frontier in driving the shift from tissue repair to regeneration. Regen Biomater. 2023;10:rbad070.
Lin W, Chen S, Wang Y, Wang M, Lee WY-W, Jiang X, et al. Dynamic regulation of mitochondrial-endoplasmic reticulum crosstalk during stem cell homeostasis and aging. Cell Death Dis. 2021;12(9):794.
Atashi F, Modarressi A, Pepper MS. The role of reactive oxygen species in mesenchymal stem cell adipogenic and osteogenic differentiation: a review. Stem Cells Dev. 2015;24(10):1150-63.
Naik PP, Birbrair A, Bhutia SK. Mitophagy-driven metabolic switch reprograms stem cell fate. Cell Mol Life Sci. 2019;76(1):27-43.
Yan W, Diao S, Fan Z. The role and mechanism of mitochondrial functions and energy metabolism in the function regulation of the mesenchymal stem cells. Stem Cell Res Ther. 2021;12(1):140.
Quinn KP, Sridharan GV, Hayden RS, Kaplan DL, Lee K, Georgakoudi I. Quantitative metabolic imaging using endogenous fluorescence to detect stem cell differentiation. Sci Rep. 2013;3:3432.
Malekpour K, Hazrati A, Soudi S, Hashemi SM. Mechanisms behind therapeutic potentials of mesenchymal stem cell mitochondria transfer/delivery. J Control Release. 2023;354:755-69.
Alexander JF, Seua AV, Arroyo LD, Ray PR, Wangzhou A, Heibeta-Luckemann L, et al. Nasal administration of mitochondria reverses chemotherapy-induced cognitive deficits. Theranostics. 2021;11(7):3109-30.
Hong X, Isern J, Campanario S, Perdiguero E, Ramirez-Pardo I, Segales J, et al. Mitochondrial dynamics maintain muscle stem cell regenerative competence throughout adult life by regulating metabolism and mitophagy. Cell Stem Cell. 2022;29(9):1298-314 e10.
Cheng XT, Huang N, Sheng ZH. Programming axonal mitochondrial maintenance and bioenergetics in neurodegeneration and regeneration. Neuron. 2022;110(12):1899-923.
Chang MM, Hong YK, Hsu CK, Harn HI, Huang BM, Liu YH, et al. Histone Trimethylations and HDAC5 Regulate Spheroid Subpopulation and Differentiation Signaling of Human Adipose-Derived Stem Cells. Stem Cells Transl Med. 2024;13(3):293-308.
Volker-Albert M, Bronkhorst A, Holdenrieder S, Imhof A. Histone Modifications in Stem Cell Development and Their Clinical Implications. Stem Cell Rep. 2020;15(6):1196-205.
Huang CW, Lu SY, Huang TC, Huang BM, Sun HS, Yang SH, et al. FGF9 induces functional differentiation to Schwann cells from human adipose derived stem cells. Theranostics. 2020;10(6):2817-31.
Qiu X, Mao Q, Tang Y, Wang L, Chawla R, Pliner HA, et al. Reversed graph embedding resolves complex single-cell trajectories. Nat Methods. 2017;14(10):979-82.
Huang TC, Wu HL, Chen SH, Wang YT, Wu CC. Thrombomodulin facilitates peripheral nerve regeneration through regulating M1/M2 switching. J Neuroinflamm. 2020;17(1):240.
Casanova A, Wevers A, Navarro-Ledesma S, Pruimboom L. Mitochondria: It is all about energy. Front Physiol. 2023;14:1114231.
Li Q, Gao Z, Chen Y, Guan MX. The role of mitochondria in osteogenic, adipogenic and chondrogenic differentiation of mesenchymal stem cells. Protein Cell. 2017;8(6):439-45.
Hsueh YY, Chang YJ, Huang TC, Fan SC, Wang DH, Chen JJ, et al. Functional recoveries of sciatic nerve regeneration by combining chitosan-coated conduit and neurosphere cells induced from adipose-derived stem cells. Biomaterials. 2014;35(7):2234-44.
Trumpff C, Michelson J, Lagranha CJ, Taleon V, Karan KR, Sturm G, et al. Stress and circulating cell-free mitochondrial DNA: A systematic review of human studies, physiological considerations, and technical recommendations. Mitochondrion. 2021;59:225-45.
Byappanahalli AM, Omoniyi V, Noren Hooten N, Smith JT, Mode NA, Ezike N, et al. Extracellular vesicle mitochondrial DNA levels are associated with race and mitochondrial DNA haplogroup. iScience. 2024;27(1):108724.
Horiguchi M, Hata S, Tsurudome Y, Ushijima K. Characterizing the degeneration of nuclear membrane and mitochondria of adipose-derived mesenchymal stem cells from patients with type II diabetes. J Cell Mol Med. 2021;25(9):4298-306.
Liang R, Arif T, Kalmykova S, Kasianov A, Lin M, Menon V, et al. Restraining Lysosomal Activity Preserves Hematopoietic Stem Cell Quiescence and Potency. Cell Stem Cell. 2020;26(3):359-76 e7.
Khacho M, Harris R, Slack RS. Mitochondria as central regulators of neural stem cell fate and cognitive function. Nat Rev Neurosci. 2019;20(1):34-48.
Kasahara A, Scorrano L. Mitochondria: from cell death executioners to regulators of cell differentiation. Trends Cell Biol. 2014;24(12):761-70.
Chen CT, Shih YR, Kuo TK, Lee OK, Wei YH. Coordinated changes of mitochondrial biogenesis and antioxidant enzymes during osteogenic differentiation of human mesenchymal stem cells. Stem Cells. 2008;26(4):960-8.
Yoon H, Park SG, Kim HJ, Shin HR, Kim KT, Cho YD, et al. Nicotinamide enhances osteoblast differentiation through activation of the mitochondrial antioxidant defense system. Exp Mol Med. 2023;55(7):1531-43.
Comas F, Latorre J, Ortega F, Oliveras-Canellas N, Lluch A, Ricart W, et al. Permanent cystathionine-beta-Synthase gene knockdown promotes inflammation and oxidative stress in immortalized human adipose-derived mesenchymal stem cells, enhancing their adipogenic capacity. Redox Biol. 2021;42:101668.
Higuchi M, Dusting GJ, Peshavariya H, Jiang F, Hsiao ST, Chan EC, et al. Differentiation of human adipose-derived stem cells into fat involves reactive oxygen species and Forkhead box O1 mediated upregulation of antioxidant enzymes. Stem Cells Dev. 2013;22(6):878-88.
Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, Cuff J, et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell. 2006;125(2):315-26.
Guo SM, Liu XP, Tian Q, Fei CF, Zhang YR, Li ZM, et al. Regulatory roles of alternative splicing at Ezh2 gene in mouse oocytes. Reprod Biol Endocrinol. 2022;20(1):99.
Ozes AR, Pulliam N, Ertosun MG, Yilmaz O, Tang J, Copuroglu E, et al. Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity. Oncogene. 2018;37(26):3589-600.
Ahmadian M, Suh JM, Hah N, Liddle C, Atkins AR, Downes M, et al. PPARgamma signaling and metabolism: the good, the bad and the future. Nat Med. 2013;19(5):557-66.
Rosen ED, Sarraf P, Troy AE, Bradwin G, Moore K, Milstone DS, et al. PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell. 1999;4(4):611-7.
Wu D, Eeda V, Undi RB, Mann S, Stout M, Lim HY, et al. A novel peroxisome proliferator-activated receptor gamma ligand improves insulin sensitivity and promotes browning of white adipose tissue in obese mice. Mol Metab. 2021;54:101363.
Mierzejewski K, Paukszto L, Kurzynska A, Kunicka Z, Jastrzebski JP, Makowczenko KG, et al. PPARgamma regulates the expression of genes involved in the DNA damage response in an inflamed endometrium. Sci Rep. 2022;12(1):4026.
Cataldi S, Aprile M, Melillo D, Mucel I, Giorgetti-Peraldi S, Cormont M, et al. TNFalpha Mediates Inflammation-Induced Effects on PPARG Splicing in Adipose Tissue and Mesenchymal Precursor Cells. Cells. 2021;11(1).
Landi S, Moreno V, Gioia-Patricola L, Guino E, Navarro M, de Oca J, et al. Association of common polymorphisms in inflammatory genes interleukin (IL)6, IL8, tumor necrosis factor alpha, NFKB1, and peroxisome proliferator-activated receptor gamma with colorectal cancer. Cancer Res. 2003;63(13):3560-6.
Yeligar SM, Kang BY, Bijli KM, Kleinhenz JM, Murphy TC, Torres G, et al. PPARgamma Regulates Mitochondrial Structure and Function and Human Pulmonary Artery Smooth Muscle Cell Proliferation. Am J Respir Cell Mol Biol. 2018;58(5):648-57.
Yu L, Chen S, Liang Q, Huang C, Zhang W, Hu L, et al. Rosiglitazone reduces diabetes angiopathy by inhibiting mitochondrial dysfunction dependent on regulating HSP22 expression. iScience. 2023;26(4):106194.
Tan Y, Richards D, Coyle RC, Yao J, Xu R, Gou W, et al. Cell number per spheroid and electrical conductivity of nanowires influence the function of silicon nanowired human cardiac spheroids. Acta Biomater. 2017;51:495-504.

Download PDF

Reviewers agreed at journal
20 Oct, 2024
Reviewers invited by journal
17 Oct, 2024
Editor assigned by journal
13 Oct, 2024
First submitted to journal
10 Oct, 2024

You are reading this latest preprint version

Enhanced Mitochondrial Function and Delivery from Adipose-Derived Stem Cell Spheres via the EZH2-H3K27me3-PPARγ Pathway for Advanced Therapy

Status:

Version 1

Abstract

Background

Methods

Results

Conclusion

Figures

Background

Materials and methods

Results

Chitosan nanodeposited surface induced 3D ASC spheres formation and mitochondria morphological changes

ASC sphere formation induced specific mitochondria subpopulation

Enhancing mitochondrial ATP production after sphere formation and the essential roles of chitosan and ASCs

Regulatory network and H3K27me3-EZH2 pathway for mitochondrial activations in ASC spheres

PPARγ as EZH2 key downstream pathway to boost mitochondria functions during ASC sphere formation

Sphere-enhanced mitochondria rescue inflamed cells and integrate with endogenous mitochondria

Discussion

Conclusion

Abbreviations

Declarations

References

Supplementary Files

Status:

Version 1